首页 /研究 /181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study
OTHER

181P TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study

Zhiyong Huang, J. Zhou, Meng Yang, Weidong Zhang, Yu Sun, Hongwei Lu, Hua Wang, Xinyu Bi, Ying Zhang, Jian Zhao, Yi Yang, Baoquan Zhang, F. Ye, Hong Zhao

发表年份
2023
引用次数
2
访问权限
开放获取

关键词

MedicineHepatocellular carcinomaPerioperativeClinical endpointRegimenInternal medicinePhases of clinical researchGastroenterologySurgeryOncology

相关论文

查看 OTHER 分类全部论文